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The leaves of Dorstenia mannii are used in traditional medicine in Cameroon and other African 
countries for the treatment of infectious diseases like malaria, skin rashes and stomach disorders. To 
substantiate this folkloric claim, the crude methanol extract and fractions from the leaves of D. mannii 
were investigated for their antifungal activity. The crude methanol extract was prepared from powdered 
dried leaves of the D. mannii. A portion was subjected to flash liquid chromatography on silica gel to 
afford test fractions. All test samples were screened for major groups of phytochemicals.Test samples 
and nystatin (reference) were evaluated for antifungal activity on ten yeasts using agar disc diffusion 
and broth microdilution methods. The qualitative analysis of crude methanol extract and fractions of D. 
mannii leaves revealed the presence of flavonoids, phenols, steroids and cardiac glycosides. In agar 
disc diffusion assay, seven of the ten pathogenic fungal strains were sensitive to the crude methanol 
extract (7/10), n-hexane ethyl-acetate (Hex-EA) (75%) (8/10) and ethyl-acetate (100%) (8/10). The 
minimum inhibitory concentrations (MICs) for the test samples varied from 80 to 1280 µg/ml. The crude 
extract and ethyl-acetate (100%) were the most active plant samples with both fungistatic and fungicidal 
effects (MIC/MFC values from 80 to 640 µg/ml) though not as the reference drug. Candida tropicalis was 
the least sensitive to the test samples. Some fractions exerted no fungicidal actions on Cryptococcus 
neoformans, Candida lusitaniae and Candida tropicalis. The present work shows that the crude 
methanol extract and fractions (n-hexane, ethyl acetate and residue) from the leaves of D. mannii 
possess growth inhibitory effect on pathogenic yeast. The active ingredients of this plant could be an 
addition to the antifungal arsenal to opportunistic fungal yeast pathogens. 
 





Nowadays, fungal diseases have emerged and are being 
increasingly recognized as important public health 
problems owing to an ever-expanding population of 
immuno-compromised  patients   (Miceli   et    al.,   2011). 
Fungal infections are usually associated with Candida, 
Aspergillus and Cryptococcus species but those due to 
Candida species represent the main opportunistic fungal 





mortality in the population (Low and Rotstein, 2011). 
These changes are linked to the growing population of 
immuno-compromised patients. During the last three 
decades, Candida albicans has been the most prevalent 
pathogen in systemic fungal infections (Pfaller and 
Diekema, 2004). Presently, non albicans species of 
Candida account for more than 50% of fungal infections. 
The opportunistic yeast mostly reported are C. albicans, 
Candida tropicalis, Candida krusei, Candida parapsilosis, 
Candida kefyr, Candida glabrata, Candida dubliensis and 
Candida rugosa and Cryptococcus neoformans (Banerje, 
2009). Antifungal active principles are diverse and 
numerous, but few classes of them are currently available 
against yeast infections because many are toxic 
(Spampinato and Leonardi, 2013). The high morbidity 
and mortality rates associated with opportunistic yeast 
infections indicate that current antifungal therapy to 
combat candidiasis is still ineffective. The current arsenal 
of antifungal drugs is exceedingly short and no new 
antifungal drugs are expected to reach the market any 
time soon (Pierce and Lopez-Ribot, 2013). Therefore, the 
discovery of new antimicrobial agents is still relevant. 
Among the potential sources of new agents, plants have 
long been investigated because they contain many 
bioactive compounds that can be of interest in therapy.  
Dorstenia mannii Hook f. (Moraceae) is a perennial 
herb growing in the tropical rain forest of West Africa 
(Hutchinson and Dalziel, 1954). A decoction of the leaves 
is used for the treatment of many diseases, but mainly for 
rheumatism and stomach disorders (Bouquet, 1969). 
There are few pharmacological studies reported on D. 
mannii. In the genus of Dorstenia, there are many plant 
species that have been proven scientifically to exert 
antimicrobial properties (Ngadjui et al., 2000). Studies 
have shown that many species from the Dorstenia genus 
are present in different degree, and have antimicrobial 
activities (Swain et al., 1991; Abegaz and Ngadjui, 1999). 
Amongst others, in Cameroon, twigs of Dorstenia 
angusticornis have been tested for their in vitro 
antimicrobial activity (Kuete, 2007). Prenylated flavonoids 
isolated from D. mannii such as 6,8-diprenyleriodictyol 
(5), dorsmanin C (3) and dorsmanin F (7) were found to 
be potent scavengers of the stable free radical 1,1-
diphenyl-2-picrylhydrazyl (Dufall et al., 2003). Compounds 
3, 5 and 7 also inhibited Cu2+-mediated oxidation of 
human low density lipoprotein (Dufall et al., 2003). The 
twigs of Dorstenia elliptica have been tested for their in 
vitro antimicrobial activity against bacteria and fungi 
(Kuete, 2007). Some compounds from the twigs of D. 
mannii presented growth inhibitory activity mostly on 
Gram-negative bacteria and  Mycobacteria  (Mbaveng  et 





Outside these activities observed from this genus, 
traditional pharmacopoeia reveals other particular 
activities of certain species, such as anti-diabetic, anti-
cholesterol, anti-oxidant and anti-malarial properties 
(Kuete, 2007). The twigs of Dorstenia barteri are used in 
Cameroon for their antimalarial properties (Iwu et al., 
1992). In many African countries, the roots of Dorstenia 
barnimiana are used in the treatment of skin diseases 
(Iwu et al., 1992). The juices of the leaves of D. elliptica 
are used as eye drops in Congo (Bouquet, 1969). The 
decoction of leaves of Dorstenia poinsettifolia is used to 
treat infected wounds (Tsopmo et al., 1998). Dorstenia 
contrajerva is used in Bolivia like an antidote against 
snake and insect bites and also to remove worms like 
tenea (Okunji, 1998). It is equally used in Guatemala to 
treat diarrhea, in Costa-Rica, Brazil and Mexico to 
provoke menstruation (Logan, 1973). This same species 
is used in Argentina like a tonic. The roots of Dorstenia 
lanei are used as infusion against stomach ache, in 
mouth washing against tooth ache or in fraction mixed 
with the stems of Pycnanthus angolensis, plus small 
portion of white clay, to calm down head ache and fights 
rheumatism (Walker and Sillans, 1961). The roots of 
Dorstenia drakena present an anti-secretory effect, a 
diuretic activity, lachrymal activity, mydratic and 
spasmolytic activities (Kyerematen et al., 1985). The 
decoctions of the leaves and roots of Dorstenia psilurus 
are used in the treatment of rheumatism, snake bites, 
against head ache and stomach ache (Bouquet, 1969).  
To the best of our knowledge no study has investigated 
the effects of D. mannii leaf extract on yeast pathogens. 
Therefore, the present work was designed to assess the 
in vitro antifungal activity of D. mannii leaf extracts on 
some yeast pathogens. 
 
 




The harvesting of plants was done at the Nkoljobe hill in April 2011, 
in Yaounde Centre Region of Cameroon Africa; geographic 
coordinates: 3° 52' 0" North, 11° 31' 0” East. The identification of 
the plants was developed at the National Herbarium in Yaoundé, 
Centre Region according to standard procedures, and were 
conserved under the voucher specimen reference number (No. 
2135) at the National Herbarium. 
 
 
Plant extract preparation 
 
The air dried and powdered leaves of the D. mannii (1 kg) were 
soaked in  methanol  for  48 h at  room  temperature   with  constant
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stirring. Then the extract was filtered using a funnel and a filter 
paper, and then kept in a flask. Removal of the solvent from the 
obtained extract under reduced pressure yielded 45 g of a dark-
green residue that constituted the crude extract. A mass of 40 g of 
this organic extract was subjected to flash liquid chromatography on 
silica gel 60 (220 g), and eluted with n-hexane, hexane-ethyl 
acetate gradients (3:1), (1:1), (1:3), ethyl-acetate and finally with 
methanol to rinse the column, constituting the residue. A total of six 
fractions were made. The extracts were then kept separately in 






The crude methanol extract and fractions were subjected to 




Fungal strainsand growth condition  
 
The microorganisms constituted 10 yeasts (C. albicans ATCC 
24433, C. albicans ATCC 2091, C. albicans ATCC 9002, C. 
tropicalis ATCC 750 Candida lusitaniae ATCC 200950, C. 
parapsilosis ATCC 22019, C. krusei ATCC 6258, Candida 
guillermondi, C. glabrata IP 35 and C. neoformans IP 95026). The 
reference strains (ATCC) were obtained from American Type 
Culture Collection (Rockville, USA). The two IP fungal strains were 
obtained from “Institute Pasteur” (Paris, France). The fungal strains 




Preparation of paper discs and test solutions 
 
Sterile discs of 6 mm in diameter were prepared from Fisher filter 
paper P5 (Catalog No. 09-801C).  The discs were impregnated with 
the crude extract or fraction (10 µL) prepared using 
dimethylsulfoxide solution (DMSO) at the concentration of 5 mg mL-
1 (5 µg µL-1). 
 
 
Antifungal assay (Agar disc diffusion test) 
 
The disc diffusion method (Chattopadhyay et al., 2001) was 
employed for the determination of antifungal activities of the crude 
extract and fractions prepared from D. mannii leaves. Briefly, 0.1 ml 
of suspension of yeast containing 1.5 × 106 spores/ml was spread 
on Sabouraud dextrose agar medium in 90 mm Petri dishes. Filter 
paper discs, 6 mm in diameter, were impregnated with 10 μl of test 
solutions (50 µg) and placed on the seeded plates. A negative 
control was prepared using the solvent (10% DMSO) employed to 
dissolve the plant extracts. Nystatin trade name Mycostatin® (10 
μg/disc) was used as positive reference drug for fungi. The Petri 
dishes were sealed with parafilm and allowed for 30 min to permit 
migration of test samples before incubation at 35°C for 48 h. 
Antifungal activity was evaluated by observing the presence of 
growth inhibition zones around the paper discs. Each assay in this 





The minimum inhibitory concentration (MIC) of the crude methanol 
extract and fractions were determined through broth microdilution 
method in 96-well micro-titre plates (Zgoda and Porter, 2001). The 





Sabouraud Dextrose broth. The test substances were initially 
prepared in a volume of 100 μl and each test sample was added 
into the first wells of the micro-titre plate. Serial two-fold dilutions of 
these test samples were made and 100 μl of inoculum standardized 
at 2.5 × 105 CFU mL-1for yeasts (at 600 nm, Jenway 6105UV/Vis 
spectrophotometer- 50 Hz/60 Hz) (Tereschuk et al., 1997) was then 
added into each well. The last wells (N°12) served as sterility 
controls (contained broth only) or negative control (broth plus 
inoculum). This gave final concentration range of 1280 to 2.5 µg/ml 
and128 to 0.25 µg/ml for the methanol extract or fractions and 
reference substance, respectively. The plates were sealed with 
parafilm, then agitated with a plate shaker to mix their contents and 
incubated at 35°C for 48 h. The minimum inhibitory concentration 
(MIC) of each test sample was determined by visualizing the 
turbidity of the wells. The MIC corresponded to the lowest well 
concentration where no turbidity change was observed, indicating 
no growth of yeast. The minimum fungicidal concentration (MFC) 
was determined by adding 50 μl aliquots of the clear wells to 150 μl 
of freshly prepared broth medium and incubating at 35°C for 48 h. 
The MFC was regarded as the lowest concentration of test sample 
which did not produce a turbidity change as above. All tests were 





Where applicable, the data were subjected to one-way analysis of 
variance, and differences between samples at P ≤ 0.05 were 
determined by Student-Newmann-Keuls multiple range test using 







The qualitative analysis of the crude methanol extract 
and fractions of D. mannii revealed the presence of some 
classes of compounds with potential antifungal activities 
(Table 1). Alkaloids, flavonoids, tannins, phenols, steroids 
and cardiac glycosides were detected. Coumarins and 
terpernoids were not detected in all the plant test 
samples. The fractions Hex (100%) and Hex-EA (25%) 





The crude methanol extract and some fractions from the 
leaves of D. mannii showed antifungal activity. The 
growth inhibitory effect of these test samples on yeasts is 
shown in Table 2. Some of the test samples presented 
fungistatic and fungicidal activities though they were 
selectively active. Seven of the ten pathogenic fungal 
strains were sensitive to the crude methanol extract 
(7/10), Hex-EA (75%) (8/10), EA (100%) (8/10) as 
indicated with a plus sign “+”. The test samples that were 
sparingly active included Hex-EA (25%), Hex-EA (50%) 
and the residual fractions. No activity was observed for n-
hexane (100%) at 5 µg/ml
 
on all the tested yeasts for the 
discs diffusion assay. The MIC (µg/ml) and MFC (µg/ml) 
of the crude methanol extract and fractions from the 
leaves of D.  mannii  on the tested yeast are presented in  




Table 1. Phytochemical screening of D. mannii methanol extract and fractions. 
 

















Flavonoids + - - + + + - 
Alkaloids + - - - - - + 
Coumarins - - - - - - - 
Phenols + + + + + + + 
Steroids + + + + + + + 
Saponins + - - - - - + 
Tannins + - + + + + - 
Chalcones + - - + + + - 
Terpernoids - - - - - - - 
Cardiac glycosides + - - + + + + 
 



























C. albicans ATCC 2091 + - - - + + + + 
C. albicans ATCC 9002 + - + + + + - + 
C. albicans ATCC 24433 + - + + + + + + 
Candida parapsilosis + - - + + + + + 
Candida tropicalis + - - - - - - + 
Candida krusei - - - - - - - + 
Candida glabrata - - - - + + - + 
Candida lusitaniae + - - - + + - + 
Cryptococcus 
neoformans 
+ - - - + + - + 
Candida guillermondi - - - - + + - + 
 




Table 3. In this microwell dilution assay, all the test 
samples demonstrated antifungal activity including the n-
hexane (100%) fraction was previously not active. The 
MICs recorded varied from 80 to 1280 µg/ml. The crude 
methanol extract and EA (100%) were the most active 
plant test substances as they exerted both fungistatic and 
fungicidal effects on all the yeasts under study (MIC/MFC 
values from 80 to 640 µg/ml). C. tropicalis was the least 
sensitive yeast to the test samples from D. mannii leaves, 
followed by C. krusei and C. guillermondi. The reference 
substance (nystatin) inhibited the growth of all the yeasts 
under study with a MIC range from 1 to 4 µg/ml. Although, 
n-hexane (100%), Hex-EA (25%) and residue fractions 
inhibited the growth of selected yeast, their activities were 






Many studies have confirmed the role of medicinal plants 
in health maintenance and promotion, but the major 
challenge is to provide scientific evidence (Arora and 
Kaur, 1999). Therefore, the present work was designed 
to assess the in vitro antifungal activity of D. mannii leaf 
extract on some yeast pathogens. The crude methanol 
extract and fractions from the leaves of D. mannii 
presented variations in antifungal activities across the 
tested fungal strains. These variations in antifungal 
activity  could  be  due  to  the differences in the chemical 























C. albicans ATCC 2091 80/160 320/320 160/320 160/320 160/320 80/160 320/640 1/4 
C. albicans ATCC 9002 80/160 320/320 320/320 160/320 160/320 80/80 320/640 1/8 
C. albicans ATCC 24433 80/320 640/640 160/640 80/320 80/320 80/160 320/640 1/4 
Candida parapsilosis 80/160 640/640 320/640 80/320 80/320 160/320 320/640 4/4 
Candida tropicalis 80/320 na/na na/na na/na na/na 160/320 640/na 2/4 
Candida krusei 640/640 na/na 160/640 na/na na/na 80/160 na/na 1/2 
Candida glabrata 320/320 na/na 80/320 160/320 160/320 160/320 80/320 1/8 
Candida lusitaniae 160/640 640/na 640/na 160/320 160/320 160/320 640/640 4/16 
Cryptococcus neoformans 320/640 640/na 640/1280 160/320 160/320 80/320 640/640 4/16 
Candida guillermondi 160/320 na/na na/na 640/640 640/640 160/320 640/640 2/16 
 




composition of these extracts as the secondary 
metabolites of plants have many effects including 
antimicrobial properties (Cowan, 1999). In addition, the 
activity of these plant extracts could be influenced by the 
nature of the plant material or its origin as well as the 
climatic conditions in which plant grows, the plant part 
used, or the solvent used for extraction, because plants 
have different constituents depending on those factors 
(Ncube et al., 2008). Again for the same plant test 
sample (crude methanol extract and ethyl-acetate (100%) 
fraction which were most active), the sensitivity of the 
fungal strains varied considerably. In the agar disc 
diffusion assay, the n-hexane (100%) fraction did not 
exert growth inhibitory activity on all the tested yeasts. 
Other fractions like the Hex-EA (25%) and residue were 
sparingly active. Surprisingly, these test samples 
demonstrated an improved antifungal activity in the 
microdilution assay. It could be understood that antifungal 
molecules from test samples are more mobile and easily 
available to penetrate or adhere to the fungal cell wall in 
liquid medium than in solid medium.  
Antimicrobial activity of plant extracts are routinely 
classified on the basis of susceptibility tests that produce 
MIC in the range of 100 to 1000 µg/ml (Simoes et al., 
2009). The activity is considered to be significant if MIC 
values are below 100 µg mL
-1 
for crude extract and 
moderate when the MICs vary from 100 to 625 µg/ml 
(Ncube et al., 2008; Kuete, 2010). Excepting the n-
hexane (100%) fraction that exhibited weak activities, the 
other test samples inhibited the growth of most of the 
studied yeasts from significant to moderated extent. 
These antifungal results are supported by previous 
studies reporting on a candidal activity of the twigs of D. 
mannii (Mbaveng et al., 2012); antibacterial activity of the 
leaves of the same plant (Fokunang et al., 2012). A Keen 
look at the MFC values indicates that most of them are 
not more  than  fourfold  their  corresponding  MICs.  This 
proves that fungicidal effects of many tested samples 
could be expected on the sensitive strains (Mims et al., 
1993). 
Qualitative phytochemical analysis of D. mannii leaf 
extracts revealed the presence of flavonoids, alkaloids, 
phenols, steroids, tannins, saponins and cardiac 
glycosides which could contribute to the observed 
antifungal activities (Teke et al., 2011; Fankam et al., 
2011). The antimicrobial activity of flavonoids isolated 
from the genus Dorstenia have been reported (Kuete et 
al., 2007; 2010b; Mbaveng et al., 2008; Ngameni et al., 
2009). Most of the phytochemicals found act as potent 
preventive agents against microbial diseases. It is 
generally found that plants containing diverse classes of 
chemicals are of superior biological activities (Kilkenny et 
al., 2011). Thus, it may also be deduced that the higher 
the diversity and the quantity of these chemical classes a 
plant may contain, the stronger and broader the spectrum 
of biological activities the plant molecules may exhibit 
(Wangchuk et al., 2011). Among the ten pathogenic 
yeasts tested C. albicans was the most sensitive to the 
extracts, while C. krusei and C. guillermondi were the 
most resistant.  This is important since C. albicans is the 
most prevalent pathogen in systemic fungal infections 





The overall results obtained revealed that the crude 
methanol extract and fractions (n-hexane, ethyl-acetate 
and methanol residue) from the leaves of D. mannii in 
this study possess inhibitory effect on the growth of 
pathogenic yeast. These findings emphasize the 
evidence that frequent use of D. mannii leaf extracts 
could be an alternative to prevent infections from 
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